Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
A recent joint meeting was held on January 30, 2014, with the US Food and Drug
Administration (FDA), National Cancer Institute (NCI), clinical scientists, imaging experts …
Administration (FDA), National Cancer Institute (NCI), clinical scientists, imaging experts …
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
A recent meeting was held on March 22, 2019, among the FDA, clinical scientists,
pharmaceutical and biotech companies, clinical trials cooperative groups, and patient …
pharmaceutical and biotech companies, clinical trials cooperative groups, and patient …
Routine clinical brain MRI sequences for use at 3.0 Tesla
Purpose To establish image parameters for some routine clinical brain MRI pulse
sequences at 3.0 T with the goal of maintaining, as much as possible, the well‐characterized …
sequences at 3.0 T with the goal of maintaining, as much as possible, the well‐characterized …
Perfusion imaging using arterial spin labeling
Arterial spin labeling is a magnetic resonance method for the measurement of cerebral
blood flow. In its simplest form, the perfusion contrast in the images gathered by this …
blood flow. In its simplest form, the perfusion contrast in the images gathered by this …
Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years?
C Nieder, O Spanne, MP Mehta, AL Grosu, H Geinitz - Cancer, 2011 - Wiley Online Library
BACKGROUND: It is largely unknown to what extent new oncologic treatment options have
improved survival of patients with brain metastasis in recent decades. Therefore, a multi …
improved survival of patients with brain metastasis in recent decades. Therefore, a multi …
Efficacy of treatment of MS with IFNβ-1b or glatiramer acetate by monthly brain MRI in the BECOME study
Background: There are no published MRI studies comparing interferon beta 1b (IFNβ-1b)
and glatiramer acetate (GA) for treatment of relapsing multiple sclerosis (MS). Objective: To …
and glatiramer acetate (GA) for treatment of relapsing multiple sclerosis (MS). Objective: To …
Myocardial fibrosis assessment at 3-T versus 5-T myocardial late gadolinium enhancement MRI: early results
Y Guo, L Lin, S Zhao, G Sun, Y Chen, K Xue, Y Yang… - Radiology, 2024 - pubs.rsna.org
Background Cardiac MRI at 5 T has recently become available and potentially improves
tissue contrast enhancement at gadolinium chelate–enhanced T1-weighted imaging …
tissue contrast enhancement at gadolinium chelate–enhanced T1-weighted imaging …
3 T MRI: advances in brain imaging
J Alvarez-Linera - European journal of radiology, 2008 - Elsevier
Since its approval by the FDA in 2000, brain MR imaging at 3.0 T has been increasingly
used in clinical practice. Theoretically, the signal-to-noise ratio (SNR) of a 3T MR scanner …
used in clinical practice. Theoretically, the signal-to-noise ratio (SNR) of a 3T MR scanner …
Muscle–fat MRI: 1.5 tesla and 3.0 tesla versus histology
Introduction: We evaluated muscle/fat fraction (MFF) accuracy and reliability measured with
an MR imaging technique at 1.5 Tesla (T) and 3.0 T scanner strengths, using biopsy as …
an MR imaging technique at 1.5 Tesla (T) and 3.0 T scanner strengths, using biopsy as …
Gadolinium-based magnetic resonance contrast agents at 7 Tesla: in vitro T: 1: relaxivities in human blood plasma
IM Noebauer-Huhmann, P Szomolanyi… - Investigative …, 2010 - journals.lww.com
Purpose/Introduction: The aim of this study was to determine the T 1 relaxivities (r 1) of 8
gadolinium (Gd)-based MR contrast agents in human blood plasma at 7 Tesla, compared …
gadolinium (Gd)-based MR contrast agents in human blood plasma at 7 Tesla, compared …